ScholarIQanswers from OpenAlex

Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats

PaperCitations, authors & open-access status

Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats have?

ScholarIQcitation count

Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats has 12 citations in the OpenAlex counts ScholarIQ stores.

When was Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats published?

ScholarIQyear

Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats has 2024 year in the ScholarIQ index.

What is the open-access status of Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats?

ScholarIQoa status

Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats has gold oa status in the ScholarIQ index.

What is the DOI of Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats?

ScholarIQdoi

The DOI for Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats is on the source record.

What is the OpenAlex record for Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats?

ScholarIQopenalex

The OpenAlex for Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial